Gyõrffy B - Search Results

1

[Prognostic and predictive markers of malignant melanoma].

Rásó E, Barbai T, Gyõrffy B, Tímár J. Rásó E, et al. Among authors: gyorffy b. Magy Onkol. 2013 Jun;57(2):79-83. Epub 2013 May 20. Magy Onkol. 2013. PMID: 23795352 Free article. Review. Hungarian.

2

[Chemotherapy agents, response rates and mechanisms of resistance in the therapy of the colorectal carcinoma].

Tegze B, Tulassay Z, Gyôrffy B. Tegze B, et al. Among authors: gyorffy b. Magy Onkol. 2006;50(4):315-23. Epub 2007 Jan 10. Magy Onkol. 2006. PMID: 17216005 Free article. Review. Hungarian.

3

[Gene expression based multigene prognostic and predictive tests in breast cancer].

Pénzváltó Z, Mihály Z, Gyorffy B. Pénzváltó Z, et al. Among authors: gyorffy b. Magy Onkol. 2009 Dec;53(4):351-9. doi: 10.1556/MOnkol.53.2009.4.4. Magy Onkol. 2009. PMID: 20071307 Free article. Review. Hungarian.

4

Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

Tímár J, Gyorffy B, Rásó E. Tímár J, et al. Among authors: gyorffy b. Clin Exp Metastasis. 2010 Aug;27(6):371-87. doi: 10.1007/s10585-010-9307-2. Epub 2010 Feb 24. Clin Exp Metastasis. 2010. PMID: 20177751 Review.

5

Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples.

Fekete T, Rásó E, Pete I, Tegze B, Liko I, Munkácsy G, Sipos N, Rigó J Jr, Györffy B. Fekete T, et al. Among authors: gyorffy b. Int J Cancer. 2012 Jul 1;131(1):95-105. doi: 10.1002/ijc.26364. Epub 2011 Dec 2. Int J Cancer. 2012. PMID: 21858809

6

[Simplified, low-cost gene expression profiling for the prediction of outcome in breast cancer based on routine histologic specimens].

Szász AM, Ács B, Ágoston E, Sztupinszki Z, Tőkés AM, Szittya L, Székely B, Szendrői M, Li Q, Harsányi L, Tímár J, Szállási Z, Swanton C, Győrffy B, Kulka J. Szász AM, et al. Among authors: gyorffy b. Orv Hetil. 2013 Apr 21;154(16):627-32. doi: 10.1556/OH.2013.29590. Orv Hetil. 2013. PMID: 23587542 Hungarian.

7

[HER2-positive breast cancer: available targeted agents and biomarkers for therapy response].

Mihály Z, Gyõrffy B. Mihály Z, et al. Among authors: gyorffy b. Magy Onkol. 2013 Sep;57(3):147-56. Epub 2013 Feb 10. Magy Onkol. 2013. PMID: 24107820 Free article. Review. Hungarian.

8

BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters.

Madaras L, Balint N, Gyorffy B, Tokes AM, Barshack I, Yosepovich A, Friedman E, Paluch-Shimon S, Zippel D, Baghy K, Timar J, Kovalszky I, Kulka J, Szasz AM. Madaras L, et al. Among authors: gyorffy b. Pathobiology. 2016;83(1):1-12. doi: 10.1159/000439135. Epub 2015 Nov 14. Pathobiology. 2016. PMID: 26566278

9

Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.

Szendrői A, Szász AM, Kardos M, Tőkés AM, Idan R, Szűcs M, Kulka J, Nyirády P, Szendrői M, Szállási Z, Győrffy B, Tímár J. Szendrői A, et al. Among authors: gyorffy b. Oncotarget. 2016 Jul 5;7(27):42086-42098. doi: 10.18632/oncotarget.9669. Oncotarget. 2016. PMID: 27244898 Free PMC article.

10

[Internet-based opportunities in breast cancer diagnostics and research].

Nagy Á, Gyõrffy B. Nagy Á, et al. Among authors: gyorffy b. Magy Onkol. 2016 Nov 29;60(4):273-280. Epub 2015 Dec 18. Magy Onkol. 2016. PMID: 27898745 Free article. Review. Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

459 results

Search Page

Filters